|
LIMA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.65569999999971E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06309999994936E-06 |
| Normal-vs-Stage2 |
1.979250E-04 |
| Normal-vs-Stage3 |
5.406800E-04 |
| Normal-vs-Stage4 |
7.620500E-03 |
| Stage1-vs-Stage2 |
6.949600E-01 |
| Stage1-vs-Stage3 |
3.856800E-01 |
| Stage1-vs-Stage4 |
9.964800E-01 |
| Stage2-vs-Stage3 |
3.025400E-01 |
| Stage2-vs-Stage4 |
7.780200E-01 |
| Stage3-vs-Stage4 |
6.243600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.31100000000129E-05 |
| Normal-vs-AfricanAmerican |
8.479700E-03 |
| Normal-vs-Asian |
3.407600E-02 |
| Caucasian-vs-AfricanAmerican |
9.779900E-02 |
| Caucasian-vs-Asian |
9.314600E-01 |
| AfricanAmerican-vs-Asian |
6.132800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.73009999999896E-05 |
| Normal-vs-Female |
5.039600E-03 |
| Male-vs-Female |
1.010950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.569900E-04 |
| Normal-vs-Extreme_Weight |
1.558390E-04 |
| Normal-vs-Obese |
3.393000E-04 |
| Normal-vs-Extreme_Obese |
1.764640E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.794200E-01 |
| Normal_Weight-vs-Obese |
7.224800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.274780E-01 |
| Extreme_Weight-vs-Obese |
4.970000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.009800E-01 |
| Obese-vs-Extreme_Obese |
3.860100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.154000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.24500000000672E-05 |
| Normal-vs-Age(61-80Yrs) |
1.72491000000052E-05 |
| Normal-vs-Age(81-100Yrs) |
2.611000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.316040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.044640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.949700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.062800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.973600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.369000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.90839999983872E-07 |
| Normal-VS-Type2 PRCC |
8.815000E-04 |
| Normal-VS-KIRP CIMP |
7.002000E-01 |
| Normal-VS-Unclassified PRCC |
3.580200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.426030E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.68060000005354E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
1.472220E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.631540E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.282000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.883500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.24219999952935E-07 |
| Normal-vs-N1 |
2.463100E-03 |
| Normal-vs-N2 |
6.128400E-01 |
| N0-vs-N1 |
1.932430E-01 |
| N0-vs-N2 |
3.396600E-01 |
| N1-vs-N2 |
3.229000E-01 |
|
|
